NUCLEOPHOSMIN 1-MUTATED ACUTE MYELOID LEUKEMIA

Clinical trials for NUCLEOPHOSMIN 1-MUTATED ACUTE MYELOID LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new NUCLEOPHOSMIN 1-MUTATED ACUTE MYELOID LEUKEMIA trials appear

Sign up with your email to follow new studies for NUCLEOPHOSMIN 1-MUTATED ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for Tough-to-Treat leukemia: experimental drug enters human trials

Disease control Recruiting now

This study is testing whether adding an experimental drug called ziftomenib to standard leukemia treatments is safe and effective. It will involve 420 adults with acute myeloid leukemia (AML) who have specific genetic changes in their cancer cells. The main goals are to find the …

Matched conditions: NUCLEOPHOSMIN 1-MUTATED ACUTE MYELOID LEUKEMIA

Phase: PHASE1 • Sponsor: Kura Oncology, Inc. • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

NUCLEOPHOSMIN 1-MUTATED ACUTE MYELOID LEUKEMIA

Get alerted when new NUCLEOPHOSMIN 1-MUTATED ACUTE MYELOID LEUKEMIA trials appear

New hope for Tough-to-Treat leukemia: experimental drug enters human trials